Drawing for NIS4

USPTO serial 88384897

NIS4

Reviewed by CopyMark Law Group

Reg. 6056468Status 700Renewal
Filing date
Status date
Registration date
May 19, 2020
Examiner
FLETCHER, TRACY L
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NIS4?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ronald M. Kachmarik

Ronald M. Kachmarik Cooper Legal Group LLC1388 Ridge Road, Unit 1Hinckley, OH 44233United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of metabolic disorders and liver diseases; diagnostic preparations for treatment of metabolic disorders and liver diseases; diagnostic testing materials for medical use, namely, reagents, nucleotide sequences, enzymes, nucleotides for blood testing, reagents kit, chemical product, biomarking agents, blood derived samples namely, plasma, serum, platelets, platelets free samples, red blood cells and white cells all for treatment of metabolic disorders and liver diseases; diagnostic agents for pharmaceutical and medical use, namely, for the treatment of metabolic disorders, liver diseases, medical diagnostic reagents and assays for testing of body fluids for treatment of metabolic disorders and liver diseases, chemical products in the nature of chemical diagnostic preparations for diagnostic tests for medical or clinical use for the diagnostic tests all for treatment of metabolic disorders and liver diseases; radio-isotope markers for therapeutic or diagnostic use for treatment of metabolic disorders and liver diseasesACTIVE—
009Downloadable software for use in database mining in the field of metabolic disorders and liver diseases and in permitting the transmission and exchange of biological data between users; optical, weighing, measuring and testing scientific apparatus and instruments in the field of clinical research and diagnostics for use in genetic and enzymatic research of metabolic disorders and liver diseases, namely, sequencers, genetic analyzer machines, biochips, and enzymatic activity readersACTIVE—
010Surgical and medical apparatus and instruments, namely, apparatus for measuring NASH, liver fibrosis, cirrhosis, ASH, NAFLD, and liver injury, and non-invasive diagnostic apparatus and instruments for detecting liver injury; tools and instruments for medical diagnostics, namely, diagnostic medical devices for diagnosis of liver diseases, blood analysis apparatus, DNA and RNA analysis apparatus, gene analyzers, medical devices for measuring biochemical and physical parameters, namely, concentration of biomarkers relating to the evaluation of liver diseases, and blood analyzers for evaluation of liver diseasesACTIVE—
044Medical health care consultancy services in the field of metabolic disorders and liver diseases; Medical information in the field of metabolic disorders and liver diseases; compilation of medical reports in the nature of compiling data for research purposes in the field of metabolic disorders and liver diseases; medical science and medical consultancy in the field of metabolic disorders and liver diseases; medical information services provided via the Internet in the field of metabolic disorders and liver diseases; medical diagnostic services in the field of metabolic disorders and liver diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 29, 2026PRA8POST REGISTRATION ACTION MAILED - SEC. 8—
Jul 17, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 4, 2026ES8RTEAS SECTION 8 RECEIVED—
May 19, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 19, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 3, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 3, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 12, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 24, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 24, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jan 24, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 24, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 24, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 26, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 26, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 23, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 29, 2019GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jun 29, 2019GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jun 29, 2019CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jun 22, 2019DOCKASSIGNED TO EXAMINER—
Jun 4, 2019AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jun 4, 2019ALIEASSIGNED TO LIE—
May 30, 2019PARITEAS VOLUNTARY AMENDMENT RECEIVED—
May 1, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 17, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance